421 related articles for article (PubMed ID: 27334457)
1. Modeling the spread of polio in an IPV-vaccinated population: lessons learned from the 2013 silent outbreak in southern Israel.
Yaari R; Kaliner E; Grotto I; Katriel G; Moran-Gilad J; Sofer D; Mendelson E; Miller E; Huppert A; ; Anis E; Kopel E; Manor Y; Mor O; Shulman L; Singer R; Weil M
BMC Med; 2016 Jun; 14(1):95. PubMed ID: 27334457
[TBL] [Abstract][Full Text] [Related]
2. Assessing the stability of polio eradication after the withdrawal of oral polio vaccine.
Famulare M; Selinger C; McCarthy KA; Eckhoff PA; Chabot-Couture G
PLoS Biol; 2018 Apr; 16(4):e2002468. PubMed ID: 29702638
[TBL] [Abstract][Full Text] [Related]
3. Modeling options to manage type 1 wild poliovirus imported into Israel in 2013.
Kalkowska DA; Duintjer Tebbens RJ; Grotto I; Shulman LM; Anis E; Wassilak SG; Pallansch MA; Thompson KM
J Infect Dis; 2015 Jun; 211(11):1800-12. PubMed ID: 25505296
[TBL] [Abstract][Full Text] [Related]
4. Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine - Worldwide, 2016.
Hampton LM; Farrell M; Ramirez-Gonzalez A; Menning L; Shendale S; Lewis I; Rubin J; Garon J; Harris J; Hyde T; Wassilak S; Patel M; Nandy R; Chang-Blanc D;
MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(35):934-8. PubMed ID: 27606675
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in Africa.
Cooper LV; Bandyopadhyay AS; Gumede N; Mach O; Mkanda P; Ndoutabé M; Okiror SO; Ramirez-Gonzalez A; Touray K; Wanyoike S; Grassly NC; Blake IM
Lancet Infect Dis; 2022 Feb; 22(2):284-294. PubMed ID: 34648733
[TBL] [Abstract][Full Text] [Related]
6. Combined use of inactivated and oral poliovirus vaccines in refugee camps and surrounding communities - Kenya, December 2013.
Sheikh MA; Makokha F; Hussein AM; Mohamed G; Mach O; Humayun K; Okiror S; Abrar L; Nasibov O; Burton J; Unshur A; Wannemuehler K; Estivariz CF;
MMWR Morb Mortal Wkly Rep; 2014 Mar; 63(11):237-41. PubMed ID: 24647400
[TBL] [Abstract][Full Text] [Related]
7. Prosocial polio vaccination in Israel.
Wells CR; Huppert A; Fitzpatrick MC; Pandey A; Velan B; Singer BH; Bauch CT; Galvani AP
Proc Natl Acad Sci U S A; 2020 Jun; 117(23):13138-13144. PubMed ID: 32457142
[TBL] [Abstract][Full Text] [Related]
8. An economic analysis of poliovirus risk management policy options for 2013-2052.
Duintjer Tebbens RJ; Pallansch MA; Cochi SL; Wassilak SG; Thompson KM
BMC Infect Dis; 2015 Sep; 15():389. PubMed ID: 26404632
[TBL] [Abstract][Full Text] [Related]
9. Modeling Poliovirus Transmission in Pakistan and Afghanistan to Inform Vaccination Strategies in Undervaccinated Subpopulations.
Duintjer Tebbens RJ; Pallansch MA; Cochi SL; Ehrhardt DT; Farag NH; Hadler SC; Hampton LM; Martinez M; Wassilak SGF; Thompson KM
Risk Anal; 2018 Aug; 38(8):1701-1717. PubMed ID: 29314143
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Household and Community Shedding and Transmission of Oral Polio Vaccine in Mexican Communities With Varying Vaccination Coverage.
Altamirano J; Purington N; Behl R; Sarnquist C; Holubar M; García-García L; Ferreyra-Reyes L; Montero-Campos R; Cruz-Hervert LP; Boyle S; Modlin J; van Hoorebeke C; Leary S; Huang C; Sommer M; Ferreira-Guerrero E; Delgado-Sanchez G; Canizales-Quintero S; Díaz Ortega JL; Desai M; Maldonado YA
Clin Infect Dis; 2018 Oct; 67(suppl_1):S4-S17. PubMed ID: 30376097
[TBL] [Abstract][Full Text] [Related]
11. Progress toward poliomyelitis eradication in Nigeria.
Ado JM; Etsano A; Shuaib F; Damisa E; Mkanda P; Gasasira A; Banda R; Korir C; Johnson T; Dieng B; Corkum M; Enemaku O; Mataruse N; Ohuabunwo C; Baig S; Galway M; Seaman V; Wiesen E; Vertefeuille J; Ogbuanu IU; Armstrong G; Mahoney FJ
J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S40-9. PubMed ID: 25316862
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of wild polio virus outbreak investigation and response in Ethiopia in 2013-2014: implications for prevention of outbreaks due to importations.
Tegegne AA; Braka F; Shebeshi ME; Aregay AK; Beyene B; Mersha AM; Ademe M; Muhyadin A; Jima D; Wyessa AB
BMC Infect Dis; 2018 Jan; 18(1):9. PubMed ID: 29304745
[TBL] [Abstract][Full Text] [Related]
13. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
[TBL] [Abstract][Full Text] [Related]
14. [Polio vaccines, eradication and posterradication].
Salmerón García F; Portela Moreira A; Soler Soneira M; López Hernández S; Chamorro Somoza Díaz-Sarmiento M; Pérez González I; Rubio Gómez MI; Pérez González A; Sagredo Rodríguez A; Ruiz Antúnez S; Timón Jiménez M; Frutos Cabanillas G
Rev Esp Salud Publica; 2013; 87(5):497-505. PubMed ID: 24322286
[TBL] [Abstract][Full Text] [Related]
15. Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization.
Sarnquist C; Holubar M; García-García L; Ferreyra-Reyes L; Delgado-Sánchez G; Cruz-Hervert LP; Montero-Campos R; Altamirano J; Purington N; Boyle S; Modlin J; Ferreira-Guerrero E; Canizales-Quintero S; Díaz Ortega JL; Desai M; Maldonado YA
Clin Infect Dis; 2018 Oct; 67(suppl_1):S115-S120. PubMed ID: 30376084
[TBL] [Abstract][Full Text] [Related]
16. Budget impact of polio immunization strategy for India: introduction of one dose of inactivated poliomyelitis vaccine and reductions in supplemental polio immunization.
Khan MM; Sharma S; Tripathi B; Alvarez FP
Public Health; 2017 Jan; 142():31-38. PubMed ID: 28057194
[TBL] [Abstract][Full Text] [Related]
17. Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use.
Duintjer Tebbens RJ; Hampton LM; Thompson KM
BMC Infect Dis; 2016 Jun; 16():237. PubMed ID: 27246198
[TBL] [Abstract][Full Text] [Related]
18. Polio endgame: the global introduction of inactivated polio vaccine.
Patel M; Zipursky S; Orenstein W; Garon J; Zaffran M
Expert Rev Vaccines; 2015 May; 14(5):749-62. PubMed ID: 25597843
[TBL] [Abstract][Full Text] [Related]
19. Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil's National Immunization Program.
Domingues CM; de Fátima Pereira S; Cunha Marreiros AC; Menezes N; Flannery B
J Infect Dis; 2014 Nov; 210 Suppl 1(0 1):S143-51. PubMed ID: 25316829
[TBL] [Abstract][Full Text] [Related]
20. Successful control of poliomyelitis by a combined OPV/IPV polio vaccine program in the West Bank and Gaza, 1978-93.
Tulchinsky T; Abed Y; Handsher R; Toubassi N; Acker C; Melnick J
Isr J Med Sci; 1994; 30(5-6):489-94. PubMed ID: 8034509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
